A Phase I Clinical Study to Evaluate the Mass Balance of [14C]SIM0270 in Healthy Chinese Adult Subjects
Latest Information Update: 29 Nov 2024
Price :
$35 *
At a glance
- Drugs SCR-6852 (Primary)
- Indications Brain metastases; Breast cancer
- Focus Pharmacokinetics
- Sponsors Jiangsu Simcere Pharmaceutical
- 27 Nov 2024 Status changed from recruiting to active, no longer recruiting.
- 28 Oct 2024 New trial record